Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination-Reference-Cited by-同舟云学术

Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination

Published:2016-07-15 Issue:7 Volume:17 Page:1140
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Orsi Andrea,Ansaldi Filippo,Trucchi Cecilia,Rosselli Roberto^ORCID,Icardi Giancarlo

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/7/1140/pdf

Reference68 articles.

1. Clinical and economic burden of pneumococcal disease in older US adults

2. Burden of Community-Acquired Pneumonia in North American Adults

3. Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study

4. Community-Acquired Pneumonia

5. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PspA-mediated aggregation protects Streptococcus pneumoniae against desiccation on fomites;mBio;2023-12-19

2. PspA-mediated aggregation protectsStreptococcus pneumoniaeagainst desiccation on fomites;2023-09-29

3. Vaccinating Welders against Pneumococcus: Evidence from a Systematic Review and Meta-Analysis;Vaccines;2023-09-15

4. Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study;Vaccine;2023-09

5. Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population;Vaccines;2022-11-28